Allen Institute for Artificial Intelligence
supp.ai logo
supp.ai

Discover Supplement-Drug Interactions

Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: 3 years ago

Possible Interaction: Agmatine and Clonidine

supplement:

Agmatine

Research Papers that Mention the Interaction

Clonidine synergized the effect of agmatine on avoidance response following nicotine withdrawal.
In separate experiments, &agr;2‐adrenoceptor agonist, clonidine (0.5–1&mgr;g/rat, icv) not only demonstrated significant increase in the step through latency as in nicotine withdrawn rats but also potentiated the pharmacological effect of agmatine.
Pharmacology Biochemistry and Behavior  •  2018  |  View Paper
The orexigenic effect of agmatine and GABAergic agonists was potentiated by a α2-adrenoceptors agonist, clonidine (10ng/rat, i.c.v.)
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie  •  2017  |  View Paper
In combination studies, the anticompulsive-like effect of agmatine (10mg/kg, ip) was significantly potentiated by prior administration of moxonidine (0.25mg/kg, ip) or clonidine (30µg/kg,) or 2-BFI (5mg/kg, ip).
European journal of pharmacology  •  2014  |  View Paper
Both moxonidine and clonidine failed to affect carbachol or adenosine-triphosphate-induced contractions; however, 1000.0 µmol/L agmatine significantly increased these contractions.
Canadian journal of physiology and pharmacology  •  2012  |  View Paper
Coadministration of agmatine (20 microg, icv) and alpha(2)-adrenoreceptors agonist, clonidine (0.1 microg, icv) evoked synergistic inhibition of nicotine sensitization.
Behavioural Brain Research  •  2010  |  View Paper
Interestingly, the vasopressor responses to exogenous noradrenaline, which remained unaffected during the infusions of physiological saline, B-HT 933, moxonidine, cirazoline and agmatine , were significantly blocked during the infusions of clonidine or methoxamine.
Autonomic Neuroscience  •  2008  |  View Paper
Only the highest dose of agmatine (1000 µg/kg) did reverse the antihypertensive effects of rilmenidine and clonidine.
Yet agmatine produced a small tachycardia at relatively low doses and was able to reverse the bradycardia induced by clonidine.
Clinical and experimental hypertension  •  2005  |  View Paper
Agmatine concentration‐dependently inhibited the binding of [3H]‐clonidine and [3H]‐rauwolscine to rat brain cortex membranes (Ki values 6 μM and 12 μM, respectively).
In addition, 30 and 100 μM agmatine increased the rate of association and decreased the rate of dissociation of [3H]‐clonidine resulting in an increased affinity of the radioligand for the α2D‐adrenoceptors.
British journal of pharmacology  •  2000  |  View Paper
Agmatine when administered at the highest well-tolerated dose of 10 micrograms/kg did not further alter the clonidine-induced hypotension but produced a greater bradycardia (-12 +/- 4 beats/min clonidine; -29 +/- 4 beats/min clonidine plus agmatine ; p < 0.05).
Neurochemistry International  •  1997  |  View Paper
In vitro, agmatine inhibits binding of clonidine to alpha 2-adrenergic and imidazoline receptors.
Physiology & Behavior  •  1996  |  View Paper
Show More